FORA Capital’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Buy
+651
New +$230K 0.01% 529
2025
Q3
– Sell
-5,520
Closed -$1.21M – 693
2025
Q2
$1.21M Buy
+5,520
New +$1.18M 0.13% 190
2024
Q4
– Sell
-8,498
Closed -$2.55M – 622
2024
Q3
$2.55M Buy
8,498
+7,789
+1,099% +$2.39M 0.3% 98
2024
Q2
$234K Buy
+709
New +$251K 0.03% 341
2024
Q1
– Sell
-6,837
Closed -$2.41M – 590
2023
Q4
$2.41M Buy
6,837
+3,928
+135% +$1.39M 0.21% 135
2023
Q3
$1.09M Sell
2,909
-5,917
-67% -$2.29M 0.1% 235
2023
Q2
$3.38M Buy
+8,826
New +$3.15M 0.48% 63
2022
Q3
– Sell
-4,298
Closed -$1.3M – 605
2022
Q2
$1.3M Buy
4,298
+3,688
+605% +$1.2M 0.26% 125
2022
Q1
$255K Buy
610
+149
+32% +$58.3K 0.05% 428
2021
Q4
$216K Sell
461
-200
-30% -$86.1K 0.08% 280
2021
Q3
$281K Sell
661
-1,486
-69% -$626K 0.07% 290
2021
Q2
$771K Buy
2,147
+1,596
+290% +$527K 0.14% 182
2021
Q1
$155K Buy
+551
New +$158K 0.05% 331
2020
Q2
– Sell
-6,001
Closed -$914K – 1363
2020
Q1
$914K Buy
6,001
+3,333
+125% +$513K 0.2% 135
2019
Q4
$401K Buy
+2,668
New +$388K 0.04% 448

Other funds holding WST

FORA Capital's WST Position: Q3 2026 in Review

FORA Capital opened a new position in West Pharmaceutical (WST) in Q3 2026: 651 shares worth $241K. The stake represents 0.01% of the portfolio and ranks #529 among its holdings. This is a return to the name: FORA Capital previously reported a position in WST as recently as Q2 2025.

FORA Capital first reported a position in WST in Q4 2019 and has held it in 15 quarters since. The position peaked at $3.38M in Q2 2023. 830 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • FORA Capital held 651 shares of West Pharmaceutical worth $241K as of Q3 2026.
  • West Pharmaceutical was a new FORA Capital position in Q3 2026.
  • West Pharmaceutical made up 0.01% of FORA Capital's portfolio in Q3 2026, its #529 holding.
  • FORA Capital first reported a position in West Pharmaceutical in Q4 2019 and has held it in 15 quarters since.
  • FORA Capital's West Pharmaceutical position peaked at $3.38M in Q2 2023.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on FORA Capital's 13F filing for Q3 2026, filed 13 Nov 2026.